CT-scan screening for heart disease fails to show benefit

March 23, 2015- Interviewed by Steven E. Greer, MD

We interviewed the Principal Investigator of the PROMISE trial, Pamela Douglas, MD from Duke. Continue reading

Posted in - NEJM, - Policy, Cardiology, CMS, Duke, Radiology | Leave a comment

What Steve Jobs would have invented if he had lived longer

Steve-JobsUpdate January 29, 2014- Apple posted Q4 earnings so big that they are incomprehensible. Continue reading

Posted in - Medical Devices, - Opinion | Leave a comment

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

May 23, 2017- interviewed by Steven E. Greer, MD

We interviewed polumonologist Michael Wechsler, MD about his paper in the NEJM testing mepolizumab Continue reading

Posted in - NEJM, National Jewish Health, Pulmonology, Rheumatology | Leave a comment

The super shady methods of pricing generic drugs in America: case study- Sildenafil

Generic revatioMay 15, 2016- by Steven E. Greer, MD

The last I read, Teva and Mylan were not supposed to launch their approved generic of Viagra (sildenafil) Continue reading

Posted in - Generics, - Opinion, - Pharma, CMS, Congress, FDA | Leave a comment

What 1982’s Blade Runner got right about 2019

September 3, 2017- by Steven E. Greer, MD

I watched again the 1982 classic Blade Runner. Directed by Ridley Scott and starring Harrison Ford, Continue reading

Posted in - Opinion, - Reviews, books, devices, Genetics, Geriatrics, Obstetrics and Gynecology, Oncology, Ophthalmology | Leave a comment

Review of immunotherapy and targeted therapy

June 17, 2016- interviewed by Steven E. Greer, MD

We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, to go over the Continue reading

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

Maybe my brain was spared

July 26, 2017- by Steven E. Greer, MD

Last week, I sat next to an Ohio State University offensive lineman while attending a Roger Waters Continue reading

Posted in - JAMA, - Reviews, books, devices, Neurology, Neurosurgery, Ohio State, Ohio State | 1 Comment

Current surgical weight loss therapies

January 24, 2014- Interviewed by Steven E. Greer, MD

Erik Dutson, MD, weight loss surgeon at UCLA, explains why his medical center does not implant the Lap-Band, Continue reading

Posted in - Medical Devices, Bariatric surgery, General surgery, UCLA | Leave a comment

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

February 27, 2017- interviewed by Steven E. Greer, MD

We interviewed Joaquim Bellmunt, MD, PhD, the Director of the Bladder Cancer Center at Dana-Farber, Continue reading

Posted in - Biotech, - NEJM, - Pharma, Harvard, Oncology | Leave a comment

Reliable gun violence statistics

Newtown kid victimsFebruary 12, 2013 By Steven E. Greer, MD

In the wake of the Newtown, Connecticut massacre of 20 first graders and six brave adults, Continue reading

Posted in - Policy, Congress, Emergency medicine, NIH, Pediatrics, Psychology Psychiatry, Trauma Surgery | Leave a comment

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

January 12, 2017- Interviewed by Steven E. Greer, MD

Jonathan Strosberg, MD of Continue reading

Posted in - NEJM, Oncology | Leave a comment

The FDA pathway for biosimilar drug approvals

March 26, 2015- Interviewed by Steven E. Greer,

Posted in - Biotech, - Generics, FDA | Leave a comment

How the FDA regulates compounding pharmacies

April 5, 2015- Interviewed by Steven E. Greer, MD

Few people knew what a compounding pharmacy was until a meningitis outbreak traced to the Continue reading

Posted in - Policy, FDA | 1 Comment

Told you so: The White House Press Office Is In Chaos

August 16, 2017- The White Announced that Hope Hicks will be the interim communications director. Continue reading

Posted in - Opinion, - Policy, Congress | Leave a comment

A modern medical wonder finishes second in the U.S. Open golf tournament

Erik-Compton-at-US-OpenJune 15, 2014- By Steven E. Greer, MD

34-year-old Erik Compton finished tied for second in the United States Open golf tournament. Continue reading

Posted in - Opinion, Cardiology, Transplant surgery | Leave a comment

The NIH has turned into a source of welfare for bloated universities

Collins-NIHSeptember 12, 2017- Science reports, “President Donald Trump’s administration has brought a long-simmering debate over how the U.S. government supports university research Continue reading

Posted in - Opinion, Congress, NIH | 1 Comment

Vagal nerve stimulation for weight loss

January 22, 2015- Interviewed by Steven E. Greer, MD

Erik Dutson, MD, bariatric surgeon from UCLA, discusses the newly FDA-approved weight loss device called Continue reading

Posted in - Medical Devices, Bariatric surgery, Diabetes and endocrinology, Gastroenterology and liver, Primary care medicine, UCLA | Leave a comment

Review of combination immunotherapies seen at ASCO 2016

June 22, 2016- interviewed by Steven E. Greer, MD

We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, Continue reading

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

Avoid ER’s attached to tertiary care hospitals

August 17, 2017- by Steven E. Greer, MD

Posted in - Opinion, - Policy, CMS, Emergency medicine | Leave a comment

CDER Director Janet Woodcock on new drug safety strategies

November 16, 2010- by Steven E. Greer, MD

We interviewed Dr. Janet Woodcock, long-time Director of CDER, the FDA center responsible Continue reading

Posted in - Pharma, FDA | Leave a comment